ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

UNCA Biology Club gears up for international competition – The Blue Banner

Continue reading

2017-04-28 Michael Zand NEWS

Current CRISPR Patent Dispute, Explained – CALIFORNIA

Current CRISPR Patent Dispute, ExplainedCALIFORNIAThey invented CRISPR-Cas9, a gene editing tool that uses a protein found in Streptococcus bacteria to chop up and rearrange viral DNA with precision. The implications of the technology were immediately … Continue reading

2017-04-28 Michael Zand NEWS

Stem cells edited to fight arthritis: Goal is vaccine that targets inflammation in joints – Medical Xpress

UNCA Biology Club gears up for international competition
The Blue Banner
UNC Asheville’s student-run Synthetic Biology Club plans to compete for the first time in a worldwide competition taking place this October. The International Genetically Engineered Machine Competition, held in Boston, Massachusetts, brings together …

Continue reading

2017-04-28 Michael Zand NEWS

Stem cells edited to fight arthritis: Goal is vaccine that targets … – Science Daily


Medical Xpress

Stem cells edited to fight arthritis: Goal is vaccine that targets inflammation in joints
Medical Xpress
Using CRISPR technology, a team of researchers led by Farshid Guilak, PhD, at Washington University School of Medicine in St. Louis, rewired stem cells‘ genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation.
Gene editing technology may produce arthritis vaccineBel Marra Health

all 3 news articles »

Continue reading

2017-04-28 Michael Zand NEWS

$10 million settlement over alleged misconduct in Boston heart stem cell lab – Science Magazine


Science Daily

Stem cells edited to fight arthritis: Goal is vaccine that targets …
Science Daily
Using CRISPR technology, a team of researchers rewired stem cells’ genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter …
Fighting arthritis: Researchers edit stem cells to fight inflammationKasmir Monitor
CRISPR-SMART Cells Regenerate Cartilage, Secrete Anti-Arthritis DrugGenetic Engineering & Biotechnology News

all 6 news articles »

Continue reading

2017-04-27 Michael Zand NEWS

Nanoparticle Vaccine Immunotherapy Targets Several Cancers – Bioscience Technology

Nanoparticle Vaccine Immunotherapy Targets Several CancersBioscience TechnologyNow, researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle immunotherapy that has a single-polymer composition. The vaccine contain… Continue reading

2017-04-27 Michael Zand NEWS

Benefit to defray cost of stem cell treatment set for May 7 – WatertownDailyTimes.com


Science Magazine

$10 million settlement over alleged misconduct in Boston heart stem cell lab
Science Magazine
A research misconduct investigation of a prominent stem cell lab by the Harvard University–affiliated Brigham and Women’s Hospital (BWH) in Boston has led to a massive settlement with the U.S. government over allegations of fraudulently obtained …
Harvard teaching hospital to pay $10 million to settle research misconduct allegationsRetraction Watch (blog)
Partners HealthCare and Brigham and Women’s Hospital to pay $10M to settle fraud allegationMassLive.com
Brigham and Women’s Pays $10 Million for Fraud AllegationsPatch.com

all 17 news articles »

Continue reading

2017-04-27 Michael Zand NEWS

Immunotherapy Demonstrates Early Promise Across Lymphoma Subgroups – OncLive

Benefit to defray cost of stem cell treatment set for May 7
WatertownDailyTimes.com
CARTHAGE — To help defray the costs of a Carthage native’s stroke treatment, friends and family will host a benefit from 1 to 6 p.m. Sunday, May 7, at the Bassett-Baxter American Legion Post 789, 415 West St. A stroke left Cynthia Wright completely …

Continue reading

2017-04-27 Michael Zand NEWS
  • 1
  • …
  • 1,791
  • 1,792
  • 1,793
  • 1,794
  • 1,795
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OncLive

Immunotherapy Demonstrates Early Promise Across Lymphoma Subgroups
OncLive
During the 2017 OncLive® State of the Science Summit on Hematologic Malignancies, Stephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, lectured on the state of immunotherapy in lymphoma. In an interview, he shared insight on the …